AnalyzeDirect Magdy Selim et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. The Lancet Neurology.
Publication Date
March 18, 2019
How Analyze was Used
“Areas of the haematoma and perihaematomal oedema were automatically delineated with imaging analysis software (Analyze 11.0 Visualization and Analysis Software for Medical Imaging; AnalyzeDirect, Overland Park, KS.)”
Keywords
Intracerebral haemorrhage, Iron chelator, Deferoxamine mesylate
Author Affiliation(s)
Beth Israel Deaconess Medical Center, Boston, MA, USA
